Top

Published in:

01-07-2007 | Brief Report

Pre-pubertal induction of experimental diabetes protects against early renal macrophage infiltration

Authors: Subrata K. Biswas, Jose B. Lopes de Faria

Published in: Pediatric Nephrology | Issue 7/2007

Abstract

The present study was undertaken to identify whether the age at induction of experimental diabetes modifies macrophage infiltration in the kidney. Renal macrophage infiltration was studied 10 days after the induction of experimental diabetes in 4-week-old pre-pubertal and 12-week-old adult male rats of normotensive [Wistar-Kyoto (WKY) rats] and hypertensive (spontaneously hypertensive rats, SHRs) background. Renal macrophage infiltration was evaluated by immunohistochemistry for ED1. Plasma glucose levels were similar in all diabetic groups. Adult SHRs were hypertensive, and induction of diabetes did not alter blood pressure (BP) in any group. Induction of diabetes in pre-pubertal rats did not induce macrophage infiltration in the kidney. However, in adult rats, tubulointerstitial macrophage infiltration was increased in both WKY (22.86 ± 3.93 vs 7.86 ± 2.16 per high-power field, P < 0.001) and SHR (26.41 ± 5.91 vs 11.48 ± 1.23, P < 0.001) groups after induction of diabetes. Glomerular macrophage infiltration was also increased after induction of diabetes in the adult WKY group (1.83 ± 0.50 vs 1.16 ± 0.26 per glomerular cross section, P = 0.029), which was not significant in the adult SHRs (2.52 ± 0.34 vs 1.95 ± 0.35). We conclude that the pre-pubertal induction of diabetes apparently protects against early renal macrophage infiltration, while the induction of diabetes in adults induces exaggerated macrophage infiltration in the kidney.

Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type I diabetes. Am J Med 78:785–794CrossRef

Donaghue KC, Fairchild JM, Craig ME, Chan AK, Hing S, Cutler LR, Howard NJ, Silink M (2003) Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care 26:1224–1229CrossRef

Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C (2005) Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294:1782–1787CrossRef

Svensson M, Nystrom L, Schon S, Dahlquist G (2006) Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care 29:538–542CrossRef

Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, Howie AJ, Adu D, Cockwell P (2006) The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 69:1189–1197CrossRef

Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH (2004) Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65:116–128CrossRef

Nguyen D, Ping F, Mu W, Hill P, Atkins RC, Chadban SJ (2006) Macrophage accumulation in human progressive diabetic nephropathy. Nephrology 11:226–231CrossRef

Yonemoto S, Machiguchi T, Nomura K, Minakata T, Nanno M, Yoshida H (2006) Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus. Clin Exp Nephrol 10:186–192CrossRef

Biswas SK, Lopes de Faria JB (2006) Hypertension induces oxidative stress but not macrophage infiltration in the kidney in the early stage of experimental diabetes mellitus. Am J Nephrol 26:415–422CrossRef

10.

Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, Usui H, Nagase R, Ogawa D, Okada S, Shikata Y, Wada J, Makino H (2005) Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia 48:2402–2411CrossRef

11.

Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J (1995) Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935–944CrossRef

12.

Eardley KS, Cockwell P (2005) Macrophages and progressive tubulointerstitial disease. Kidney Int 68:437–455CrossRef

13.

Lane PH (2002) Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol 283:589–600CrossRef

14.

Lane PH, Snelling DM, Hollman A, Langer WJ (2001) Puberty permits increased expression of renal transforming growth factor-β1 in experimental diabetes. Pediatr Nephrol 16:1033–1039CrossRef

15.

Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97:8015–8020CrossRef

Title: Pre-pubertal induction of experimental diabetes protects against early renal macrophage infiltration
Authors: Subrata K. Biswas
Jose B. Lopes de Faria
Publication date: 01-07-2007
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 7/2007
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-007-0453-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pre-pubertal induction of experimental diabetes protects against early renal macrophage infiltration

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2007

A patient with hyperuricemia and renal failure:question

OCRL1 mutations in patients with Dent disease phenotype in Japan

The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection

Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients

Rapamycin retards growth and causes marked alterations in the growth plate of young rats

Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration